Bone Biologics - Warrants (13/10/2026) Net Tangible Assets

As of the most recent data (June 2026), BBLGW shows a net tangible assets of $3.9M. That compares with $6.6M in the prior-year period — down 40.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BBLGW's net tangible assets is now $3.9M (was $6.6M) — a 40.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bone Biologics - Warrants (13/10/2026) is outperforming or lagging.

Tracking BBLGW's net tangible assets over time shows whether Bone Biologics - Warrants (13/10/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $3.9M That compares with $6.6M in the prior-year period — down 40.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Bone Biologics - Warrants (13/10/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $3.9M) with ownership activity and broader fundamentals.